淋球菌耐药机制和治疗策略研究进展  

Countermeasures against Drug Resistance in Neisseria Gonorrhoeae:Research Advances

作　　者：罗晶晶 戎成婷 惠磊 吴新安 张旺 LUO Jing-jing;RONG Cheng-ting;HUI Lei;WU Xin-an;ZHANG Wang(Hefei Boe Hospital,Hefei 230011,China;The Third People's Hospital of Hefei,Hefei 230011,China)

机构地区：[1]合肥京东方医院,安徽合肥230011 [2]合肥市第三人民医院,安徽合肥230011

出　　处：《解放军药学学报》2024年第1期80-83,共4页Pharmaceutical Journal of Chinese People's Liberation Army

基　　金：安徽医科大学校基金资助项目,No.2022xkj132。

摘　　要：淋球菌是引起淋病的病原体,淋球菌对抗生素的耐药性不断增加,影响淋病的有效治疗。随着耐药淋球菌株的不断增加,其临床治疗难度也越来越大。本文就近年来对淋球菌的耐药进展、耐药机制、治疗研究等方面进行综述。Neisseria gonorrhoeae is a gonorrhea-causing pathogen.The resistance of neisseria gonorrhoeae to antibiotics is increasing,which adversely affects the treatment of gonorrhea.This article reviews the progress in research on drug resistance,mechanisms of drug resistance and treatments of gonococcal in recent years.

关 键 词：淋球菌 耐药性 淋病治疗 

分 类 号：R969[医药卫生—药理学]